About Us
Centaro Biosciences develops therapeutics designed for the realities of clinical care. We focus on diseases where treatment success depends on sustained exposure, reliable adherence, and practical dosing in healthcare systems with limited capacity.
By aligning pharmacology with disease biology and real-world treatment conditions, we advance medicines intended to improve both patient outcomes and health-system efficiency. Our programmes prioritize durability, scalability, and measurable impact in high-burden settings.
Who We Are
Our mission is to redefine chronic disease management by reducing dosing frequency and treatment burden, minimizing avoidable adverse effects, and improving adherence, clinical outcomes, and healthcare efficiency in resource-limited settings.
To become a leading developer of impactful therapeutics that translate rigorous science into accessible patient benefit – with limited-resource regions as the primary setting for clinical relevance, innovation, and health impact.
Patient-centred Impact
We prioritise therapies that address real and urgent health needs. Clinical benefit and adherence improvement guide every development decision.
Innovation
We translate the latest scientific advances into practical solutions that improve outcomes for patients and health systems.
Pragmatic Development
We advance programmes through practical pathways and strategies that enable adoption and scalability in resource-limited healthcare systems.
Collaboration
We value trusted relationships with healthcare providers, patient advocacy groups, industry partners, regulators, and communities. Meaningful health impact requires coordinated effort across the full healthcare ecosystem.
Sustainable Value
We pursue development programmes to generate enduring benefit for patients and partners in resource-limited healthcare systems.
Leadership Team
Centaro Biosciences is led by a multidisciplinary team with deep expertise across clinical development, translational science, regulatory strategy, and clinical operations. Our leadership combines industry and academic experience to efficiently advance innovative therapeutics from concept to clinic.